×
Thank you for your registration, kindly check your email for an update.
Thank you for your registration!
Kindly check your email for confirmation and we will be keeping you posted about the upcoming event.
See you soon!
OK
Raising the bar in chronic kidney disease management
| Time (SGT) | Topic | Speaker |
|---|---|---|
| 6:00 PM | Faculty introductions and scientific agenda | Dr Anita Sharma |
| 6:10 PM | Checkpoint #1: Evidence and practice interactive session (Slido) | Dr Anita Sharma |
| 6:20 PM | Your role in early screening diagnosis and treatment in CKD | Dr Anita Sharma |
| 6:35 PM | Checkpoint #2: Evidence and practice interactive session (Slido) | Dr Anita Sharma |
| 6:45 PM | Cardio renal benefits of empagliflozin in EMPA-KIDNEY: The final piece of the puzzle | Prof David Cherney |
| 7:05 PM | Case discussion and Q & A Early stage CKD patient with a higher eGFR |
Dr Anita Sharma Prof David Cherney |
| 7:30 PM | 5 key takeaways and close | Dr Anita Sharma |
For healthcare professionals only. This webinar is for educational purposes only with the intent to communicate the EMPA-KIDNEY trial results. Empagliflozin is not indicated for the treatment of patients with chronic kidney disease in the Philippines. Please refer to the local approved product information for the current indication. Date: August 2023. RIN No: SC-PH-04498
×
Dr Anita Sharma
University of Queensland, Australia
- Practice Principal at Platinum Medical Centre, and Senior Lecturer, Primary Care Unit, University of Queensland
- Member of Education Committee, Royal College of General Practitioners (RACGP), co-author of the RACGP General Practice Management of type 2 diabetes handbook
- Special interest in Aviation Medicine and is a Designated Aviation Medical Examiner and a Medical Review Officer for Civil Aviation Authority of Australia
- Professional interests include education of GPs registrars, medical students and fellow GPs and development of education modules in type 2 diabetes, CKD, heart failure, atrial fibrillation, diabetes, osteoporosis, obesity, anaemia, and medico-legal matters
×
Prof David Cherney
University of Toronto, Canada
- Professor of Medicine: Division of Nephrology University of Toronto Ontario Canada
- Senior Scientist, Nephrology, University Health Network, Faculty of Medicine, Toronto General Hospital Research Institute, Ontario, Canada
- Director Renal Physiology Laboratory, a clinician scientist, and a physician in the Division of Nephrology at the Toronto General Hospital
- Member Canadian Society of Nephrology, American Society of Nephrology, Canadian Medical, Ontario Medical Association and Royal College of Physicians and Surgeons Canada
- The American Society of Nephrology Distinguished Researcher Award June 2019
- Research interest focuses on the relationship of T1D and renal hemodynamic function, the renin angiotensin aldosterone system, uric acid, urinary biomarkers and glucose lowering therapies
